Modulation of the endogenous antioxidants paraoxonase-1 and urate by pesticide exposure and genetic variants of xenobiotic-metabolizing enzymes

Food and Chemical Toxicology

Volumn 61, Issue , 2013, Pages 164-170

  Hernández, Antonio F ^a   Gil, Fernando ^a   Lacasaña, Marina ^b,c   Rodríguez Barranco, Miguel ^b   Gómez Martin, Antonio ^a   Lozano, David ^a   Pla, Antonio ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

Cholinesterases; Endogenous antioxidants; Occupational health; Pesticide exposure; Pesticidemetabolising gene variants

Indexed keywords

ACETYLCHOLINESTERASE; ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; ARYLESTERASE; BIOLOGICAL MARKER; DIAZOXONASE; GLUTATHIONE TRANSFERASE; PESTICIDE; UNCLASSIFIED DRUG; URATE;

ADULT; AGRICULTURAL WORKER; ARTICLE; BODY MASS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME MECHANISM; FEMALE; GENE LOCATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; LONG TERM EXPOSURE; MALE; OCCUPATIONAL HEALTH; PARAOXONASE 1 GENE; RISK ASSESSMENT; XENOBIOTIC METABOLISM;

CHOLINESTERASES; ENDOGENOUS ANTIOXIDANTS; OCCUPATIONAL HEALTH; PESTICIDE EXPOSURE; PESTICIDEMETABOLISING GENE VARIANTS;

ACETYLCHOLINESTERASE; ADOLESCENT; ADULT; AGRICULTURE; ARYLDIALKYLPHOSPHATASE; CASE-CONTROL STUDIES; FEMALE; GENE-ENVIRONMENT INTERACTION; GLUTATHIONE TRANSFERASE; HUMANS; LONGITUDINAL STUDIES; MALE; METABOLIC DETOXICATION, DRUG; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PESTICIDES; POLYMORPHISM, SINGLE NUCLEOTIDE; URIC ACID; YOUNG ADULT;

EID: 84888846170     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.05.039     Document Type: Article

References (37)

1. Agachan B., Yilmaz H., Ergen H.A., Karaali Z.E., Isbir T. Paraoxonase (PON1) 55 and 192 polymorphism and its effects to oxidant-antioxidant system in Turkish patients with type 2 diabetes mellitus. Physiol. Res. 2005, 54:287-293.
2. Aviram M., Rosenblat M., Bisgaier C.L., Newton R.S., Primo-Parmo S.L., La Du B.N. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J. Clin. Invest. 1998, 101:1581-1590.
3. Aviram M., Hardak E., Vaya J., Mahmood S., Milo S., Hoffman A., Billicke S., Draganov D., Rosenblat M. Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation 2000, 101:2510-2517.
4. Boaventura B.C., Di Pietro P.F., Stefanuto A., Klein G.A., de Morais E.C., de Andrade F., Wazlawik E., da Silva E.L. Association of mate tea (Ilex paraguariensis) intake and dietary intervention and effects on oxidative stress biomarkers of dyslipidemic subjects. Nutrition 2012, 28:657-664.
5. Browne R.O., Moyal-Segal L.B., Zumsteg D., David Y., Kofman O., Berger A., Soreq H., Friedman A. Coding region paraoxonase polymorphisms dictate accentuated neuronal reactions in chronic, sub-threshold pesticide exposure. FASEB J. 2006, 20:1733-1735.
6. Constantinescu R., Zetterberg H. Urate as a marker of development and progression in Parkinson's disease. Drugs Today (Barc.) 2011, 47:369-380.
7. Deakin S.P., James R.W. Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1. Clin. Sci. (Lond.) 2004, 107:435-447.
8. Dorandeu F., Foquin A., Briot R., Delacour C., Denis J., Alonso A., Froment M.T., Renault F., Lallement G., Masson P. An unexpected plasma cholinesterase activity rebound after challenge with a high dose of the nerve agent VX. Toxicology 2008, 248:151-157.
9. Durrington P.N., Mackness B., Mackness M.I. Paraoxonase and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2001, 21:473-480.
10. Elbaz A., Alpérovitch A. Bias in association studies resulting from gene-environment interactions and competing risks. Am. J. Epidemiol. 2002, 155:265-272.
11. Elbein S.C., Sun J., Scroggin E., Teng K., Hasstedt S.J. Role of common sequence variants in insulin secretion in familial type 2 diabetic kindreds: the sulfonylurea receptor, glucokinase, and hepatocyte nuclear factor 1alpha genes. Diabetes Care 2001, 24:472-478.
12. Ellman G.L., Courtney D.K., Andres V., Featherstone R.M. A New rapid colorimetric determinacion of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
13. Haidari F., Rashidi M.R., Mohammad-Shahi M. Effects of orange juice and hesperetin on serum paraoxonase activity and lipid profile in hyperuricemic rats. BioImpacts 2012, 2:39-45.
14. Hayden M.R., Tyagi S.C. Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle. Nutr. Metab. (Lond.) 2004, 1(1):10.
15. Hernández A.F., Mackness B., Rodrigo L., López O., Pla A., Gil F., Durrington P.N., Pena G., Parrón T., Serrano J.L., Mackness M.I. Paraoxonase activity and genetic polymorphisms in greenhouse workers with long term pesticide exposure. Hum. Exp. Toxicol. 2003, 22:565-574.
16. Hernández A., Gómez M.A., Pena G., Gil F., Rodrigo L., Villanueva E., Pla A. Effect of long-term exposure to pesticides on plasma esterases from plastic greenhouse workers. J. Toxicol. Environ. Health A 2004, 67:1095-1108.
17. Hernández A.F., López O., Rodrigo L., Gil F., Pena G., Serrano J.L., Parrón T., Álvarez J.C., Lorente J.A., Pla A. Changes in erythrocyte enzymes in humans long-term exposed to pesticides Influence of several markers of individual susceptibility. Toxicol. Lett. 2005, 159:13-21.
18. James R.W., Leviev I., Ruiz J., Passa P., Froguel P., Blatter-Garin M.C. Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients. Diabetes 2000, 49:1390-1393.
19. Junge W., Klees H. Arylesterase. Methods of Enzymatic Analysis 1984, vol. IV:8-14. Verlag Chemie, Weinheim.
20. Koroliczuk A., Chibowski D., Bełtowski J., Wójcicka G. Selected markers of oxidative stress in rats with active Heymann nephritis. Med. Sci. Monit. 2001, 7:369-376.
21. Kotani K., Tsuzaki K., Sakane N. Paraoxonase-1 gene Q192R polymorphism and reactive oxygen metabolites. J. Int. Med. Res. 2012, 40:1513-1518.
22. Laird N.M., Lange C. The Fundamentals of Modern Statistical Genetics 2011, Springer, New York, p. 102.
23. López O., Hernández A.F., Rodrigo L., Gil F., Pena G., Serrano J.L., Parrón T., Villanueva E., Pla A. Changes in antioxidant enzymes in humans with long-term exposure to pesticides. Toxicol. Lett. 2007, 171:146-153.
24. Lotito S.B., Frei B. Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon. Free Radic. Biol. Med. 2006, 41:1727-1746.
25. Milatovic D., Aschner M., Gupta R.C., Zaja-Milatovic S., Barnes G. Involvement of oxidative stress in anticholinesterase pesticide toxicity. Anticholinesterase Pesticides. Metabolism, Neurotoxicity and Epidemiology 2010, 135-147. Wiley, Hoboke, New Jersey. T. Satoh, R.C. Gupta (Eds.).
26. Ogut S., Gultekin F., Kisioglu A.N., Kucukoner E. Oxidative stress in the blood of farm workers following intensive pesticide exposure. Toxicol. Ind. Health 2011, 27:820-825.
27. Perła-Kaján J., Jakubowski H. Paraoxonase 1 and homocysteine metabolism. Amino Acids. 2012, 43:1405-1417.
28. Rajković M.G., Rumora L., Juretić D., Grubisić T.Z., Flegar-Mestrić Z., Vrkić N., Sinjeri Z., Barisić K. Effect of non-genetic factors on paraoxonase 1 activity in patients undergoing hemodialysis. Clin. Biochem. 2010, 43:1375-1380.
29. Richter R.J., Furlong C.E. Determination of paraoxonase (PON1) status requires more than genotyping. Pharmacogenetics 1999, 9:745-753.
30. Richter E.D., Chuwers P., Levy Y., Gordon M., Grauer F., Marzouk J., Levy S., Barron S., Gruener N. Health effects from exposure to organophosphate pesticides in workers and residents in Israel. Isr. J. Med. Sci. 1992, 28:584-598.
31. Shen, H., 2011. Responses of Paraoxonase 1 to Dioxin-like PCB 126 (3,3',4,4',5-Pentachlorobiphenyl): Mechanisms and Consequences. Thesis dissertation, Iowa University < http://ir.uiowa.edu/etd/2770.
32. Shetty J.K., Prakash M., Verma M., Tripathy S., Vickram P. Effect of atorvastatin on paraoxonase activity in patients with hyperlipidemia. Asian J. Biochemistry. 2008, 3:139-142.
33. Sözmen E.Y., Mackness B., Sözmen B., Durrington P., Girgin F.K., Aslan L., Mackness M. Effect of organophosphate intoxications on human serum paraoxonase. Hum. Exp. Toxicol. 2002, 21:247-252.
34. Sözmen, E.Y., Sagin, F.G., Kayikciogly, M., Sozmen, B., 2008. Oxidative Stress & Antioxidants and PON1 in Health and Disease. In: Mackness, B., Mackness, M., Aviram, M., Paragh, G. (Eds.), The Paraoxonases: their Role in Disease Development and Xenobiotic Metabolism. Springer Netherlands, pp. 61-73.
35. Tinoco-Ojanguren R., Halperin D.C. Poverty, production, and health: inhibition of erythrocyte cholinesterase via occupational exposure to organophosphate insecticides in Chiapas. Mexico. Arch. Environ. Health 1998, 53:29-35.
36. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell. Biol. 2007, 39:44-84.
37. Whittaker M. Cholinesterases. Methods of Enzymatic Analysis 1984, vol. IV:52-74. Verlag Chemie, Weinheim.